$CXAI bull case is relatively straightforward: tiny valuation, real enterprise AI software, and a market still pricing the company like execution will fail.
Recent quarterly revenue was only around $950K, but the more interesting metrics were:
\~98% subscription revenue
\~83% gross margins
\~$1.4M bookings
and over $5M in new multi-year enterprise contract value
For a company sitting around a roughly $10–15M market cap, that’s why some traders think the current valuation disconnect is worth watching. If management can successfully scale its workplace AI and “CXAI 2.0” platform, even moderate SaaS traction could justify a materially different valuation profile over time.
The recent dilution also appears largely understood by the market at this point. Share float has expanded from roughly 69M to near 100M shares, with shares issued around the $0.15 range through the Avondale financing structure. By the way the agreement on this deal made between CXAI and Avondale is they’re not allowed holding more than 9,99% of the company because they’re buying the shares with a discount and that’s the reason they got shares from 15-27 May instead of all shares the 15 May they had to sell the shares before getting new shares and with the announcement today the dilution in this round is finished. From management’s perspective, the financing was likely necessary to maintain operations and continue the platform transition.
Right now many traders seem focused on:
\- CXAI 2.0 launch updates
\- future enterprise PR
\- and whether the company can maintain recurring revenue growth
Technically, the stock still appears to be trading within its broader recent range while traders monitor longer timeframe MACD trends and weighted average support levels.
Still extremely speculative, but the combination of AI infrastructure narrative, enterprise software positioning, done with dilution, recurring revenue, and microcap valuation is why CXAI continues appearing on speculative AI watchlists.
